Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer

To clarify the relationship between dose-volume histogram (DVH) parameters and radiation pneumonitis (RP) after surgery in cases of non-small cell lung cancer (NSCLC) treated with induction concurrent chemoradiotherapy (CCRT). Patients with NSCLC treated with induction CCRT (chemotherapy: cisplatin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta medica Okayama 2018-10, Vol.72 (5), p.507-513
Hauptverfasser: Ogata, Takeshi, Katsui, Kuniaki, Yoshio, Kotaro, Ihara, Hiroki, Katayama, Norihisa, Soh, Junichi, Kuroda, Masahiro, Kiura, Katsuyuki, Maeda, Yoshinobu, Toyooka, Shinichi, Kanazawa, Susumu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 513
container_issue 5
container_start_page 507
container_title Acta medica Okayama
container_volume 72
creator Ogata, Takeshi
Katsui, Kuniaki
Yoshio, Kotaro
Ihara, Hiroki
Katayama, Norihisa
Soh, Junichi
Kuroda, Masahiro
Kiura, Katsuyuki
Maeda, Yoshinobu
Toyooka, Shinichi
Kanazawa, Susumu
description To clarify the relationship between dose-volume histogram (DVH) parameters and radiation pneumonitis (RP) after surgery in cases of non-small cell lung cancer (NSCLC) treated with induction concurrent chemoradiotherapy (CCRT). Patients with NSCLC treated with induction CCRT (chemotherapy: cisplatin and docetaxel; radiotherapy: 2.0 Gy fractions once daily for a total of 46 Gy) before surgery were reviewed. We calculated the percentage of lung volume receiving at least 20 Gy (V20) and the mean lung dose (MLD) for the total lung volume and the lung remaining after resection. Factors affecting the incidence of RP at grade 2 or higher (≥ G2 RP) were analyzed. Eighteen of 49 patients (37%) experienced ≥G2 RP. The V20 and MLD for the lung remaining after resection (V20r and MLDr) were significant predictors according to the multivariate analysis (p=0.007 and 0.041, respectively). The incidence of ≥G2 RP was 8% in patients with V20r
doi_str_mv 10.18926/AMO/56249
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2126913677</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2126913677</sourcerecordid><originalsourceid>FETCH-LOGICAL-j345t-660ac5a5155d089721a931ad3c20fea707a2f7c1dd9eedfd70cd85533e45af633</originalsourceid><addsrcrecordid>eNo1kMtOwzAQRb0A0VLY8AHISzahTlw7ybIKr0qFVrzELhrsSZuqsYsfQv0I_pmIx2bu6OroaDSEnKXsMi3KTI6n94uxkNmkPCBDxguZcMbeBuTY-w1jfS3ZERlwxmW_FUPydWU9Jq92GzukS3DQYUDn6dKhblWgj6BbCK01dGkwdta0ofUUmh6iT9Gt0O3pZxvWdGZ0VD9gZY2KzqEJtFpjZ12vsGGNDnZ72lhHH6xJfAfbLa2wH_NoVrQCo9CdkMMGth5P_3JEXm6un6u7ZL64nVXTebLhExESKRkoASIVQrOizLMUSp6C5ipjDULOcsiaXKVal4i60TlTuhCCc5wIaCTnI3Lx6905-xHRh7prveqPAYM2-jpLM1mmXOZ5j57_ofG9Q13vXNuB29f_L-TfXKxzXA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2126913677</pqid></control><display><type>article</type><title>Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer</title><source>MEDLINE</source><source>Freely Accessible Japanese Titles</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ogata, Takeshi ; Katsui, Kuniaki ; Yoshio, Kotaro ; Ihara, Hiroki ; Katayama, Norihisa ; Soh, Junichi ; Kuroda, Masahiro ; Kiura, Katsuyuki ; Maeda, Yoshinobu ; Toyooka, Shinichi ; Kanazawa, Susumu</creator><creatorcontrib>Ogata, Takeshi ; Katsui, Kuniaki ; Yoshio, Kotaro ; Ihara, Hiroki ; Katayama, Norihisa ; Soh, Junichi ; Kuroda, Masahiro ; Kiura, Katsuyuki ; Maeda, Yoshinobu ; Toyooka, Shinichi ; Kanazawa, Susumu</creatorcontrib><description>To clarify the relationship between dose-volume histogram (DVH) parameters and radiation pneumonitis (RP) after surgery in cases of non-small cell lung cancer (NSCLC) treated with induction concurrent chemoradiotherapy (CCRT). Patients with NSCLC treated with induction CCRT (chemotherapy: cisplatin and docetaxel; radiotherapy: 2.0 Gy fractions once daily for a total of 46 Gy) before surgery were reviewed. We calculated the percentage of lung volume receiving at least 20 Gy (V20) and the mean lung dose (MLD) for the total lung volume and the lung remaining after resection. Factors affecting the incidence of RP at grade 2 or higher (≥ G2 RP) were analyzed. Eighteen of 49 patients (37%) experienced ≥G2 RP. The V20 and MLD for the lung remaining after resection (V20r and MLDr) were significant predictors according to the multivariate analysis (p=0.007 and 0.041, respectively). The incidence of ≥G2 RP was 8% in patients with V20r&lt;10%, and 13% in patients with MLDr&lt;5.6 Gy, respectively. The optimal approach to reduce the rate of postoperative RP in patients with induction CCRT for NSCLC is to keep the V20r below 10% and/or the MLDr below 5.6 Gy in the radiotherapy planning.</description><identifier>ISSN: 0386-300X</identifier><identifier>DOI: 10.18926/AMO/56249</identifier><identifier>PMID: 30369608</identifier><language>eng</language><publisher>Japan</publisher><subject>Aged ; Carcinoma, Non-Small-Cell Lung - therapy ; Chemoradiotherapy ; Dose-Response Relationship, Radiation ; Female ; Humans ; Incidence ; Lung Neoplasms - therapy ; Male ; Middle Aged ; Radiation Pneumonitis - epidemiology ; Radiotherapy Dosage</subject><ispartof>Acta medica Okayama, 2018-10, Vol.72 (5), p.507-513</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30369608$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ogata, Takeshi</creatorcontrib><creatorcontrib>Katsui, Kuniaki</creatorcontrib><creatorcontrib>Yoshio, Kotaro</creatorcontrib><creatorcontrib>Ihara, Hiroki</creatorcontrib><creatorcontrib>Katayama, Norihisa</creatorcontrib><creatorcontrib>Soh, Junichi</creatorcontrib><creatorcontrib>Kuroda, Masahiro</creatorcontrib><creatorcontrib>Kiura, Katsuyuki</creatorcontrib><creatorcontrib>Maeda, Yoshinobu</creatorcontrib><creatorcontrib>Toyooka, Shinichi</creatorcontrib><creatorcontrib>Kanazawa, Susumu</creatorcontrib><title>Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer</title><title>Acta medica Okayama</title><addtitle>Acta Med Okayama</addtitle><description>To clarify the relationship between dose-volume histogram (DVH) parameters and radiation pneumonitis (RP) after surgery in cases of non-small cell lung cancer (NSCLC) treated with induction concurrent chemoradiotherapy (CCRT). Patients with NSCLC treated with induction CCRT (chemotherapy: cisplatin and docetaxel; radiotherapy: 2.0 Gy fractions once daily for a total of 46 Gy) before surgery were reviewed. We calculated the percentage of lung volume receiving at least 20 Gy (V20) and the mean lung dose (MLD) for the total lung volume and the lung remaining after resection. Factors affecting the incidence of RP at grade 2 or higher (≥ G2 RP) were analyzed. Eighteen of 49 patients (37%) experienced ≥G2 RP. The V20 and MLD for the lung remaining after resection (V20r and MLDr) were significant predictors according to the multivariate analysis (p=0.007 and 0.041, respectively). The incidence of ≥G2 RP was 8% in patients with V20r&lt;10%, and 13% in patients with MLDr&lt;5.6 Gy, respectively. The optimal approach to reduce the rate of postoperative RP in patients with induction CCRT for NSCLC is to keep the V20r below 10% and/or the MLDr below 5.6 Gy in the radiotherapy planning.</description><subject>Aged</subject><subject>Carcinoma, Non-Small-Cell Lung - therapy</subject><subject>Chemoradiotherapy</subject><subject>Dose-Response Relationship, Radiation</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Lung Neoplasms - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Radiation Pneumonitis - epidemiology</subject><subject>Radiotherapy Dosage</subject><issn>0386-300X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kMtOwzAQRb0A0VLY8AHISzahTlw7ybIKr0qFVrzELhrsSZuqsYsfQv0I_pmIx2bu6OroaDSEnKXsMi3KTI6n94uxkNmkPCBDxguZcMbeBuTY-w1jfS3ZERlwxmW_FUPydWU9Jq92GzukS3DQYUDn6dKhblWgj6BbCK01dGkwdta0ofUUmh6iT9Gt0O3pZxvWdGZ0VD9gZY2KzqEJtFpjZ12vsGGNDnZ72lhHH6xJfAfbLa2wH_NoVrQCo9CdkMMGth5P_3JEXm6un6u7ZL64nVXTebLhExESKRkoASIVQrOizLMUSp6C5ipjDULOcsiaXKVal4i60TlTuhCCc5wIaCTnI3Lx6905-xHRh7prveqPAYM2-jpLM1mmXOZ5j57_ofG9Q13vXNuB29f_L-TfXKxzXA</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Ogata, Takeshi</creator><creator>Katsui, Kuniaki</creator><creator>Yoshio, Kotaro</creator><creator>Ihara, Hiroki</creator><creator>Katayama, Norihisa</creator><creator>Soh, Junichi</creator><creator>Kuroda, Masahiro</creator><creator>Kiura, Katsuyuki</creator><creator>Maeda, Yoshinobu</creator><creator>Toyooka, Shinichi</creator><creator>Kanazawa, Susumu</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20181001</creationdate><title>Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer</title><author>Ogata, Takeshi ; Katsui, Kuniaki ; Yoshio, Kotaro ; Ihara, Hiroki ; Katayama, Norihisa ; Soh, Junichi ; Kuroda, Masahiro ; Kiura, Katsuyuki ; Maeda, Yoshinobu ; Toyooka, Shinichi ; Kanazawa, Susumu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j345t-660ac5a5155d089721a931ad3c20fea707a2f7c1dd9eedfd70cd85533e45af633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Carcinoma, Non-Small-Cell Lung - therapy</topic><topic>Chemoradiotherapy</topic><topic>Dose-Response Relationship, Radiation</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Lung Neoplasms - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Radiation Pneumonitis - epidemiology</topic><topic>Radiotherapy Dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ogata, Takeshi</creatorcontrib><creatorcontrib>Katsui, Kuniaki</creatorcontrib><creatorcontrib>Yoshio, Kotaro</creatorcontrib><creatorcontrib>Ihara, Hiroki</creatorcontrib><creatorcontrib>Katayama, Norihisa</creatorcontrib><creatorcontrib>Soh, Junichi</creatorcontrib><creatorcontrib>Kuroda, Masahiro</creatorcontrib><creatorcontrib>Kiura, Katsuyuki</creatorcontrib><creatorcontrib>Maeda, Yoshinobu</creatorcontrib><creatorcontrib>Toyooka, Shinichi</creatorcontrib><creatorcontrib>Kanazawa, Susumu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Acta medica Okayama</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ogata, Takeshi</au><au>Katsui, Kuniaki</au><au>Yoshio, Kotaro</au><au>Ihara, Hiroki</au><au>Katayama, Norihisa</au><au>Soh, Junichi</au><au>Kuroda, Masahiro</au><au>Kiura, Katsuyuki</au><au>Maeda, Yoshinobu</au><au>Toyooka, Shinichi</au><au>Kanazawa, Susumu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer</atitle><jtitle>Acta medica Okayama</jtitle><addtitle>Acta Med Okayama</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>72</volume><issue>5</issue><spage>507</spage><epage>513</epage><pages>507-513</pages><issn>0386-300X</issn><abstract>To clarify the relationship between dose-volume histogram (DVH) parameters and radiation pneumonitis (RP) after surgery in cases of non-small cell lung cancer (NSCLC) treated with induction concurrent chemoradiotherapy (CCRT). Patients with NSCLC treated with induction CCRT (chemotherapy: cisplatin and docetaxel; radiotherapy: 2.0 Gy fractions once daily for a total of 46 Gy) before surgery were reviewed. We calculated the percentage of lung volume receiving at least 20 Gy (V20) and the mean lung dose (MLD) for the total lung volume and the lung remaining after resection. Factors affecting the incidence of RP at grade 2 or higher (≥ G2 RP) were analyzed. Eighteen of 49 patients (37%) experienced ≥G2 RP. The V20 and MLD for the lung remaining after resection (V20r and MLDr) were significant predictors according to the multivariate analysis (p=0.007 and 0.041, respectively). The incidence of ≥G2 RP was 8% in patients with V20r&lt;10%, and 13% in patients with MLDr&lt;5.6 Gy, respectively. The optimal approach to reduce the rate of postoperative RP in patients with induction CCRT for NSCLC is to keep the V20r below 10% and/or the MLDr below 5.6 Gy in the radiotherapy planning.</abstract><cop>Japan</cop><pmid>30369608</pmid><doi>10.18926/AMO/56249</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0386-300X
ispartof Acta medica Okayama, 2018-10, Vol.72 (5), p.507-513
issn 0386-300X
language eng
recordid cdi_proquest_miscellaneous_2126913677
source MEDLINE; Freely Accessible Japanese Titles; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Aged
Carcinoma, Non-Small-Cell Lung - therapy
Chemoradiotherapy
Dose-Response Relationship, Radiation
Female
Humans
Incidence
Lung Neoplasms - therapy
Male
Middle Aged
Radiation Pneumonitis - epidemiology
Radiotherapy Dosage
title Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T09%3A10%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dose-Volume%20Parameters%20Predict%20Radiation%20Pneumonitis%20after%20Surgery%20with%20Induction%20Concurrent%20Chemoradiotherapy%20for%20Non-small%20Cell%20Lung%20Cancer&rft.jtitle=Acta%20medica%20Okayama&rft.au=Ogata,%20Takeshi&rft.date=2018-10-01&rft.volume=72&rft.issue=5&rft.spage=507&rft.epage=513&rft.pages=507-513&rft.issn=0386-300X&rft_id=info:doi/10.18926/AMO/56249&rft_dat=%3Cproquest_pubme%3E2126913677%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2126913677&rft_id=info:pmid/30369608&rfr_iscdi=true